Screening for Colorectal Cancer

Matthew Jacobsson; Vitas Wagner; Shalini Kanneganti

doi:10.1016/j.suc.2023.11.009

Screening for Colorectal Cancer

Surg Clin North Am. 2024 Jun;104(3):595-607. doi: 10.1016/j.suc.2023.11.009. Epub 2023 Dec 14.

Authors

Matthew Jacobsson¹, Vitas Wagner¹, Shalini Kanneganti²

Affiliations

¹ Virginia Mason Franciscan Health, St. Joseph Medical Center General Surgery Residency, 1708 South Yakima Avenue Suite 105 & 112, Tacoma, WA 98408, USA.
² Virginia Mason Franciscan Health, Franciscan Surgical Associates at St. Joseph, 1708 South Yakima Avenue Suite 105 & 112, Tacoma, WA 98405, USA. Electronic address: shalini.kanneganti@commonspirit.org.

PMID: 38677823
DOI: 10.1016/j.suc.2023.11.009

Abstract

Colorectal cancer remains the third leading cause of cancer death in the United States. Colorectal cancer screening allows for prevention and early detection of precancerous and cancerous lesions, and screening has been shown to be effective in preventing colorectal cancer deaths. Screening recommendations vary by patient risk profile. A variety of screening modalities exist.

Keywords: Colonoscopy; Colorectal cancer screening; Screening modalities; Screening risk stratification; Screening schedule.

Publication types

Review

MeSH terms

Colonoscopy* / methods
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / prevention & control
Early Detection of Cancer* / methods
Humans
Mass Screening / methods
Occult Blood*
United States / epidemiology